Filing Details

Accession Number:
0001104659-16-121881
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-05-18 16:31:34
Reporting Period:
2016-05-16
Filing Date:
2016-05-18
Accepted Time:
2016-05-18 16:31:34
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1660719 Aralez Pharmaceuticals Inc. ARLZ () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1441461 A Mark Glickman C/o Aralez Pharmaceuticals Inc.,
151 Steeles Avenue East
Milton A6 L9T 1Y1
Chief Commercial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares, Without Par Value Acquisiton 2016-05-16 25,000 $3.68 186,553 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from $3.64 to $3.72, inclusive. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.